Drugs can trigger biological responses that vary from individual to individual. Therefore, adverse reactions (undesired effects associated with the use of drugs) cannot be identified during clinical development prior to placement on the market. For this reason, healthcare professionals and citizens are provided with a reporting tool to allow Sophos to update the safety information for the drugs it places on the market, thus fulfilling a precise legal obligation and helping to protect public health.
If you wish to contact us directly, please read the personal data processing disclosure carefully before sending, to the addresses below, any report or request for information.
Every adverse reaction or undesired effect that occurs during or following pharmacotherapy must be promptly reported to the healthcare professional, the medical practitioner, or the pharmacist. A suspicious reaction can be reported in the following ways:
using the form available at the Agenzia Italiana del Farmaco (AIFA) website at the link to adverse reactions reporting forms, under “Data sheet for the citizen” (click here);
via the VigiFarmaco website for online reporting (click here).
For healthcare professionals
Healthcare personnel is required to report to Agenzia Italiana del Farmaco (AIFA) any adverse event associated with the use of drugs. Healthcare professionals can report a suspicious reaction in the following ways:
using the form available at the Agenzia Italiana del Farmaco (AIFA) website at the link to adverse reactions reporting forms, under “Data sheet for the healthcare professional” (click here);
via the VigiFarmaco website for online reporting (click here).
AIFA’s site offers constant pharmacovigilance updating (click here).
